Picture EBD Group World of Partnering Opportunities 650x100px

Product › Details

rhGGF-2

	Next higher product group	cytokine
	Status	1995-01-01 development existent
	Organisation	Cambridge NeuroScience Inc.
	Today	Paion (Group)
	Group	Humanwell Healthcare (Group)

Record changed: 2023-07-10

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for cytokine

[1] Slate Bio, Inc.. (1/19/21). "Press Release: Slate Bio Launches with Seed Financing to Develop Next Generation IL-2 Therapies". Charlottesville, VA....
[2] Merck KGaA. (9/29/20). "Press Release: Press Release as a Result of the Ad-hoc Announcement of September 29, 2020". Darmstadt....
[3] Savara Inc.. (12/20/19). "Press Release: Savara Announces Private Placement of $26.8 Million, With Total Potential Proceeds of $75.0 Million". Austin, TX....
[4] Sanofi S.A.. (12/9/19). "Press Release: Sanofi to Acquire Synthorx to Bolster Its Immuno-oncology Pipeline for $2.5 Billion". Paris & San Diego, CA....
[5] Savara Inc.. (11/18/19). "Press Release: Savara Appoints Badrul Chowdhury, M.D., Ph.D as Chief Medical Officer". Austin, TX....
[6] Novartis AG. (4/3/19). "Press Release: Sandoz Resubmits Biosimilar Pegfilgrastim Application to US FDA". Holzkirchen....
[7] New York Times [The Editorial Board]. (2/24/19). "News: It’s Time for Pharmaceutical Companies to Have Their Tobacco Moment"....
[8] Synthorx Inc.. (4/30/18). "Press Release: Synthorx Announces $63 Million Series C Financing to Advance a Pipeline of Synthorin Cytokines". San Diego, CA....
[9] Roche. (1/12/18). "Press Release: Roche’s Ocrevus (ocrelizumab) Approved in the European Union for Relapsing Forms of Multiple Sclerosis and Primary Progressive Multiple Sclerosis". Basel....
[10] Novartis AG. (10/28/17). "Press Release: Novartis PARADIGMS Data Show Children and Adolescents with MS Had an 82% Lower Relapse Rate with Gilenya vs. Interferon beta-1a". Basel....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]